Archive for the ‘Africa’ category

Kenya: Nation Setting Sights on Eliminating Blinding Disease

November 16th, 2011

 

Woman with trachoma. Photo credit: HKI

Just recently launching a five-year plan to eliminate NTDs, Kenya is working tirelessly to ensure that the country will soon be free of these parasitic diseases. Check out what’s currently being done in the fight against trachoma, one of the seven most common NTDs, in an article recently published in All Africa (the largest online distributor of Africa-focused news) and includes a quote from Global Network Managing Director Dr. Neeraj Mistry:

“Olenarau — Had a community health worker not found him at the rural Kenyan village of Olenarau, 65-year-old Tonke Nalakiti would still be blaming his failing sight on old age.

But the health worker, who was trained to identify patients infected with trachoma, succeeded in convincing Nalakiti that his condition could be corrected through simple surgery and antibiotics.

After a swab of iodine and a jab of anesthesia to ease the pain of incision, the elder from the remote village south of the capital, Nairobi, had the infection surgically corrected in less than 15 minutes.

National surveys indicate that Nalakiti is among some 3.4 percent of patients in Kajiado County whose trachoma has reached the blinding stage, making it a serious public health problem in that region and many other similarly remote areas with little access to health care and screening.” Click here to continue reading.

Dr. Neeraj Mistry Interviewed in Africa News Analysis

November 15th, 2011

Global Network for Neglected Tropical Diseases Managing Director Dr. Neeraj Mistry was recently interviewed by Africa News Analysis (ANA). ANA is a print and online publication that examines key issues in Africa and the Middle East  through special in-depth reports and feature stories. Editor Musah Ibrahim Musah interviewed Dr. Mistry, covering the social and economic impact of NTDs as well as discussing the cost-effective solutions that are currently available to treat them, including integration with HIV, malaria and tuberculosis. The story also features Global Network’s efforts to work with in-country partners and governments to help get treatments to those affected by NTDs in Africa and around the world. Click here to read the full interview on ANA.

New plan to eliminate NTDs in Kenya

November 10th, 2011

Mass drug administration of Albendazole in conjunction with the launch of the Kenyan national plan for NTD control and elimination.

“Africa bears 50% of the global burden of neglected tropical diseases.” Quoted from an article published in Africa Science News, neglected tropical diseases (NTDs) are perpetuating the cycle of poverty,  prohibiting African populations from reaching their potential. In Kenya alone, 1 in 2 people suffer from NTDs. Recognizing this burden, the Kenyan government has launched a five-year long national plan to address NTDs such as schistosomiasis, trachoma, leishmaniasis, intestinal worms, elephantiasis and Hydatid disease. Kenya is the first African country to launch such a plan, which will bring the country closer to becoming free from preventable diseases. Eliminating NTDs in  Kenya is also in line with Millennium Development Goal 6, along with achieving Vision 2030, which aims to turn Kenya into a middle-income nation by 2030.

Read more about Kenya’s national NTD plan on Africa Science News.

Reading List 10/25/2011

October 25th, 2011

Stay up to date on the latest NTD and global health news with our reading list! Today we’re reading about:

Pfizer Donates Zithromax, Promotes Eye Screening
AS part of its corporate social responsibility and efforts to forestall the onset of preventable eye disorders such glaucoma and trachoma which lead to blindness, Pfizer Specialities Nigeria recently held free eye screening services in Abuja, Ilorin, Kano, Osun, Akwa-Ibom and Delta States. A donation of Zithromax was officially handed to the Minister of Health in Abuja through the company’s International trachoma Initiative.

Global plan targets devastating eye disease
Blinding trachoma, one of the oldest known infectious eye diseases, may be facing its end game. The world’s leading cause of preventable blindness, trachoma brings extraordinary human suffering and economic devastation to tens of millions of people, mostly women and children in poorer countries. Yet as a result of development and targeted interventions it is now limited to an estimated 59 countries, often affecting the poorest populations in Africa and Asia.

5 districts declared filariasis disease free
Dhaka, Oct 25 (bdnews24.com) – The government has declared five districts free of the crippling mosquito-borne filariasis disease, for the first time in Bangladesh after years of mass drug administration. State minister for health Mozibur Rahman Fakir, on Tuesday, announced the name of the districts – Meherpur, Rajshahi, Dinajpur, Patuakhali and Barguna – where the prevalence rate for the parasitic disease, also known as elephantiasis, was found to be below one percent.

A Fresh Insight into Transmission of Schistosomiasis: A Misleading Tale of Biomphalaria in Lake Victoria
Lake Victoria is a known hot-spot for Schistosoma mansoni, which utilises freshwater snails of the genus Biomphalaria as intermediate hosts. Different species of Biomphalaria are associated with varying parasite compatibility, affecting local transmission. It is thought that two species, B. choanomphala and B. sudanica, inhabit Lake Victoria; despite their biomedical importance, the taxonomy of these species has not been thoroughly examined.

Economics of drug discovery, development for neglected diseases
One of the major reasons why some of the major healthcare problems related to neglected diseases are not addressed by large pharma companies is the lack of large markets which are enablers for ensuring adequate returns on the investments made. For example with rising costs of drug discovery reaching over $ 1.5 billion for every new drug reaching the market, there are not many drugs for neglected diseases which could attract adequate markets in value terms.